Reporter

Digestive Disease Research Center lands major grant

The Vanderbilt Digestive Disease Research Center (VDDRC) celebrates its 15th anniversary this year with a third consecutive five-year renewal of its federal research grant.

MLK lecturer sees teamwork as crucial to health care diversity

David Gordon, M.D., dean of the University of Akron College of Health Professions, gave the 2017 Martin Luther King Jr. Commemorative Lecture on Monday at Vanderbilt, touching on the theme of teamwork as it relates to health care diversity.

Close-up of a woolen knitted texture (blue)

Surprising finding by VU team sheds light on fibrotic disease

Integrins are membrane proteins made up of combinations of different “alpha” and “beta” subunits that enable cells throughout the body to interact with their surroundings.

COX-2 ‘conjugate’ may slow growth of some tumors: study

More than a decade after the anti-inflammatory drugs Vioxx and Bextra were pulled from the market because of a heightened risk of heart attack and stroke in some patients, COX-2 inhibitors may be on the verge of a comeback, this time as anti-cancer agents.

Newly available infographic shows vast scope of EpicLeap program

“EpicLeap by the Numbers” is a recently created infographic that gathers, in one place, an array of data points that demonstrate the remarkable magnitude of the EpicLeap program.

Study to track diabetes drug’s ability to also treat asthma

Investigators in the Division of Allergy, Pulmonary, and Critical Care Medicine and the Division of Diabetes, Endocrinology, and Metabolism recently received a $1.25 million grant from the National Institute of Allergy and Infectious Diseases.

1 379 380 381 382 383 725